Is Silica Skin Hydration Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Silica Skin Hydration Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Results According to the repeated-measures ANOVA, the control and study group had a significant reduction in follicular papule counts over time (all p Conclusion The combined formula effectively reduced follicular papules, improved skin hydration, decreased TEWL, and alleviated depressive symptoms in KP patients. [Liu F (2026); evidence level 2] - Objective Keratosis pilaris (KP) is a common follicular keratotic skin disorder characterized by follicular papules and skin roughness, often accompanied by itching and inflammation, significantly affecting appearance and psychological health. [Liu F (2026); evidence level 2] - Methods This 28-day prospective, open-label, randomized controlled study evaluated the effectiveness of a novel combined formula for KP treatment. [Liu F (2026); evidence level 2] - Background Biotin, a vital cofactor for carboxylase enzymes, plays a key role in metabolic processes, while silica is believed to support collagen synthesis, contributing to improved skin and hair health. [Patel MN (2025); evidence level 2] - Results In the post-90-day evaluation, hair fall reduced to 20.61 ± 14.39 (p < 0.001) in biotin and 15.71 ± 10.8 (p < 0.001) in biotin with silica. [Patel MN (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.